Altria Q1 2026: EPS Beats 5.6% as Marlboro Hits 59.5% Premium Share and on! PLUS Goes Nationwide

Transcript intelligence

What changed

Compared to the prior quarter (Q4 2025), where adjusted EPS grew 4.4% and the narrative centered on FDA authorizations for Helix ON PLUS and the launch of the duty drawback program, Q1 2026 showed several notable shifts. EPS growth accelerated to 7.3% YoY. on! PLUS moved from authorization to nationwide availability at ~100,000 stores, while Helix shipped 18% more volume. Marlboro's premium share climbed to 59.5%, and Basic captured additional discount share, demonstrating effective portfolio management across price tiers. The e-vapor category showed early signs of moderation as enforcement actions curtailed illicit disposable products, a dynamic management had flagged in the prior quarter when illicit e-vapor accounted for ~70% of the category. New initiatives include the upcoming Cowboy Cut Marlboro variant and continued on! PLUS flavor and strength expansion. Notably, capex outlook shifted from 'increasing' in Q4 2025 to 'not mentioned' in Q1 2026, suggesting the initial investment cycle may be stabilizing.

Guidance delta

Full-year 2026 adjusted EPS guidance of $5.56-$5.72 was reaffirmed despite the stronger Q1 print. Management cited expectations of more balanced growth between H1 and H2, implying a deceleration in subsequent quarters. This maintained guidance, rather than a raise, was a focal analyst concern given the Q1 beat created a ~$0.07 EPS cushion above the $1.25 consensus.

Key takeaways

• Adjusted diluted EPS of $1.32 beat consensus by 5.6%, with revenue of $4.76B exceeding estimates by 3.9%.
• Marlboro premium share rose to 59.5%, while Basic captured additional discount segment share.
• Helix delivered an 18% shipment volume increase; on! PLUS reached nationwide availability at ~100,000 stores.
• on! PLUS is the first nicotine pouch authorized under the FDA's pilot program, using proprietary NICOSILK technology.
• E-vapor demand showed early signs of moderation as enforcement curtailed illicit flavored disposable products.
• The stock rose 6.5% on the report but subsequently drifted -4.2%, suggesting the market initially rewarded the beat then reconsidered the unchanged guidance.

Management priorities

• Continue national expansion of on! PLUS and pursue FDA approvals for additional flavors and strengths.
• Launch Cowboy Cut, a competitively priced Marlboro variant, later in the year.
• Invest in smoke-free product innovation and advocate for faster FDA authorization timelines.
• Maintain dividend payouts and share repurchase program while managing debt levels.
• Grow duty drawback export volumes to incrementally increase the financial benefit throughout 2026.